Search Ontology:
ChEBI
ML355
- Term ID
- CHEBI:195557
- Synonyms
-
- ML 355
- ML-355
- N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxybenzyl)amino]benzenesulfonamide
- N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide
- VLX 1005
- VLX-1005
- VLX1005
- Definition
- A sulfonamide resulting from the formal condensation of the amino group of 2-aminobenzothiazole with the sulfo group of 4-[(2-hydroxy-3-methoxybenzyl)amino]benzenesulfonic acid. It is an inhibitor of 12-lipoxygenase, being developed by Veralox Therapeutics for the treatment of heparin-induced thrombocytopenia and thrombosis.
- References
-
- cas:1532593-30-8
- pdb-ccd:ZR5
- pubmed:25506969
- pubmed:28609824
- pubmed:28775075
- pubmed:32853794
- pubmed:33277254
- pubmed:33463501
- pubmed:34128835
- pubmed:34507163
- pubmed:35197320
- pubmed:37345522
- pubmed:37506345
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from ML355
Phenotype where environments contain ML355
Phenotype modified by environments containing ML355
Phenotype affecting ML355
Human Disease Model